|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 31, 2017 ) According to the report Global Influenza Market, published by Market Data Forecast, the global market is projected to reach USD 9.33 billion with a CAGR of 8.54% from USD 5.97 billion in 2016.
For full report refer to http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
Influenza or flu is a transmittable respiratory disease which affect nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be either seasonal, pandemic, or zoonotic. Influenza can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. According to World Health Organization, the flu occurs annually infecting 5% to 10% adults and 20% to 30% children, worldwide. Approximately, 3 to 5 million people gets severely infected resulting in 250,000 – 500,000 deaths. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
Free sample of the report is available at http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries are not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies.
Avail discount at http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-discount
Segmentation:
Based on Product Type
• Vaccines
• Drugs
Based on Consumer
• Children
• Adults
Geographical Segmentation:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
Buy now http://www.marketdataforecast.com/cart/buy-now/global-influenza-market-1704
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Marketdata Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
